Jefferies upgrades Zydus Life to ‘Buy’ on strong US pipeline potential, stock up 4%
Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a ‘Buy’ rating, citing the strength of the company’s US pipeline as a key driver for future growth. The brokerage raised …